RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sergio Arancibia

Family · la Quinta, CANPI 1881926939

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 567 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,644 and has fallen 52.7% since, to $1,724 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,481in general payments, 2019–2025

Across 567 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Astellas Pharma US Inc$807
  • Pharmacyclics LLC, An Abbvie Company$727
  • Johnson & Johnson$693
  • Incyte Corporation$540
  • Eisai Inc.$537
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$12,31891%
  • Education$1,1639%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis73$1,373
Astellas Pharma US Inc21$807
Pharmacyclics LLC, An Abbvie Company21$727
Johnson & Johnson(2 entities)26$693
Incyte Corporation28$540
Eisai Inc.24$537
Takeda Pharmaceuticals U.S.A., Inc.18$531
Amgen19$471
AbbVie25$465
Seagen Inc.19$424
Merck18$403
Pfizer18$386
AstraZeneca16$355
Bristol Myers Squibb21$355
Sanofi12$329
LEO Pharma Inc.10$322
Regeneron Healthcare Solutions, Inc.9$280
Rigel Pharmaceuticals, Inc.9$252
Lilly USA, LLC14$244
Gilead(2 entities)12$238
Taiho Oncology, Inc.8$228
Puma Biotechnology, Inc.9$225
Arcutis Biotherapeutics, Inc.12$198
Bayer8$191
Sobi, Inc5$180
Galderma Laboratories, L.p.4$179
CSL Behring7$159
GSK6$155
E.r. Squibb & Sons, L.L.C.6$128
Daiichi Sankyo Inc.6$126
Array Biopharma Inc5$111
Dova Pharmaceuticals5$106
Genentech USA, Inc.4$103
Adaptive Biotechnologies Corporation4$95
Ipsen Biopharmaceuticals, Inc4$93
Octapharma USA, Inc.2$87
Boston Scientific3$85
EUSA Pharma (US) LLC2$84
Foundation Medicine, Inc.4$79
Blueprint Medicines Corporation4$77
Immunocore Limited1$76
Epizyme, Inc.3$74
UCB, Inc.3$67
Karyopharm Therapeutics Inc.3$65
Boehringer Ingelheim3$62
Immunogen, Inc.3$61
Beigene USA, Inc.3$60
EMD Serono, Inc.3$59
Stemline Therapeutics Inc.2$53
Deciphera Pharmaceuticals Inc.2$52
Novocure Inc.2$49
Morphosys, US Inc.2$38
Agios Pharmaceuticals, Inc.2$37
Sumitomo Pharma America, Inc.2$36
Pharmaessentia USA Corporation1$33
Mirati Therapeutics, Inc.1$29
Macrogenics, Inc.1$27
Sun Pharmaceutical Industries Inc.1$24
ADC Therapeutics America, Inc.1$24
Pharmacosmos Therapeutics Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,481 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Other family in la Quinta

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →